RBC Capital analyst Gregory Renza downgraded Bellus Health to Sector Perform from Outperform with a price target of $14.75, down from $21.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BLU:
- Bellus Health downgraded to In Line from Outperform at Evercore ISI
- GSK to acquire Bellus Health for $14.75 per share
- Bellus Health Surges after Acquisition by GSK for $2 Billion
- Bellus Health management to meet with Piper Sandler
- Bellus Health announces results from camlipixant bioavailability study